IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488,559 | -9.5% | 50,733 | 0.0% | 0.32% | +0.6% |
| Q2 2023 | $539,799 | -17.1% | 50,733 | -18.0% | 0.31% | -10.1% |
| Q1 2023 | $651,125 | -15.1% | 61,894 | 0.0% | 0.35% | -1.4% |
| Q4 2022 | $766,867 | +20.6% | 61,894 | +0.8% | 0.35% | +7.0% |
| Q3 2022 | $636,000 | -10.2% | 61,416 | 0.0% | 0.33% | -4.3% |
| Q2 2022 | $708,000 | -11.9% | 61,416 | -3.9% | 0.34% | +4.9% |
| Q1 2022 | $804,000 | +3.9% | 63,906 | -3.7% | 0.33% | +5.8% |
| Q4 2021 | $774,000 | -10.2% | 66,366 | +0.5% | 0.31% | -19.6% |
| Q3 2021 | $862,000 | +1.5% | 66,008 | +0.0% | 0.39% | +1.0% |
| Q2 2021 | $849,000 | +15.0% | 65,977 | 0.0% | 0.38% | +41.9% |
| Q1 2021 | $738,000 | -1.7% | 65,977 | 0.0% | 0.27% | -10.9% |
| Q4 2020 | $751,000 | – | 65,977 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |